InMed Pharmaceuticals (INM)
NASDAQ:INM
Holding INM?
Track your performance easily

InMed Pharmaceuticals (INM) Financial Statements

324 Followers

InMed Pharmaceuticals Financial Overview

InMed Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.344; its P/E ratio is -0.17; InMed Pharmaceuticals is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.28M$ 1.17M$ 1.24M$ 901.86K$ 2.31M
Gross Profit$ 466.07K$ 289.46K$ 324.14K$ 21.24K$ 1.57M
EBIT$ -1.93M$ -1.72M$ -1.48M$ -2.54M$ -150.94K
EBITDA$ -1.78M$ -1.57M$ -1.33M$ -2.39M$ -150.94K
Net Income Common Stockholders$ -1.94M$ -1.72M$ -1.48M$ -2.54M$ -159.54K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.61M$ 7.64M$ 9.58M$ 6.78M$ 8.96M
Total Assets$ 11.82M$ 13.36M$ 15.26M$ 10.92M$ 14.11M
Total Debt$ 962.66K$ 1.07M$ 1.17M$ 293.00K$ 391.71K
Net Debt$ -5.65M$ -6.57M$ -8.41M$ -6.49M$ -8.57M
Total Liabilities$ 2.62M$ 2.25M$ 2.48M$ 1.34M$ 2.02M
Stockholders Equity$ 9.21M$ 11.10M$ 12.77M$ 9.58M$ 12.09M
Cash Flow-
Free Cash Flow----$ -817.95K
Operating Cash Flow$ -1.03M$ -1.93M$ -1.85M$ -2.17M$ -657.93K
Investing Cash Flow-$ -2.00$ -9.29K-$ -33.61K
Financing Cash Flow$ 176.00-$ 4.65M--
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

InMed Pharmaceuticals Debt to Assets

InMed Pharmaceuticals Cash Flow

InMed Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis